Summary Evidence as to the value of preoperative carcinoembryonic antigen (CEA) 
ment for each patient. The lack of reliable parameters of prox-en prognostic xalue is a limitation to preoperative planning. The Xalue of preoperative carcinoembrx onic antigen (CEA) as a prognostic indicator in patients w ith resectable colorectal cancer is conflictinc (Eskelinen et al. 1994 : Northover. 1995 : Carpelan-Holmstrom et al. 1996 .,with some studies reporting that it is of value. especialix for the more locallv advanced tumour. whereas others have been unable to show that preoperatixe CEA is an independent predictor of sun ix-al (Filella et al. 1994 : Wang et al. 1994 A'e have prexiouslx shown that the ploidy status of stage B colorectal tumours is an independent prognostic marker of survival (Chapman et al. 1995) . It may be speculated that cells
x ith an abnormal amount of nuclear DNA (aneuploid) may produce abnormal quantities of CEA compared with cells with a normal quantity of nuclear DNA (diploid). In one study. 48% (36 of 75) of patients wxith an aneuploid tumour had a raised preoperatixe CEA compared with 34% (14 of 41) of patients with diploid tumours (P < 0.05). (44) 76 (37) 182 (90) 20 (10) CEA > 10 ,ug ml-1 23 (31) 35 (46) 17 (23) 58 (77) 17 ( Patients with clinical suspicion of recurrence were investigated as appropriate by endoscopy, radiology including magnetic resonance imaging and immunoscintigraphy. If the cause of death was unknown, a post-mortem was performed to seek evidence of recurrent disease. Statistical analysis was by chi-squared test and Kaplan-Meir plots (SPSS Inc, Chicago, II, USA). In the analysis of survival, patients who died of non-colorectal cancer-related illness were censored from analysis at time of death. The results are expressed in terms of cancer-specific survival. Statistical significance was taken at P < 0.05.
RESULTS
Two hundred and eighty-six patients were entered into this study and nine (3%) deaths occurred within 30 days of surgery. These patients have been excluded from the analysis as this reflects surgical morbidity rather than tumour characteristics. The median age of patients at entry to this study was 67 (range 40-87) years. None was lost to follow-up. The median survival was 50 months, with a range of 1-126 months.
The tumour stage, distribution, number of patients with a raised preoperative CEA and histological grade of the 277 tumours are shown in Table 1 . Two hundred and two (73%) patients had a preoperative CEA < 11 gg ml-'. The number of patients with a raised preoperative CEA tended to increase with a more advanced tumour stage (chisquared test, P < 0.000001), and patients with a poorly differentiated tumour were more likely to have a raised preoperative CEA level than those with a well/moderately differentiated tumour (chisquared test, P < 0.005, Table 2 ).
Previous work has suggested that tumours having a tetraploid DNA content behave in a similar fashion to diploid tumours and so have been considered together (Chapman et al, 1995) . One hundred and twenty-two (44%) of the tumours were diploid or tetraploid and the remaining 155 were aneuploid. Ninety (74%) of the 122 patients with a diploid tumour had a preoperative CEA <11jIg ml-' compared with 112 (72%) of the 155 patients with an aneuploid tumour.
The site of the tumours was not related to an elevated CEA level (Table 2) . Interestingly, of the 164 men in the study, only 23 had right-sided tumours compared with 32 out of 113 tumours in women (chi-squared test, P < 0.005).
The overall cancer-specific survival for these patients was 52%. If those undergoing palliative surgery (stage D tumours) are excluded, the cancer-specific survival rises to 62%.
The colorectal cancer-specific survival curves for stages A,B,C and D are shown in Figure 1 and, as expected, there is a highly statistically significant difference between the curves. Patients British Joumal of Cancer (1998) 78(10), [1346] [1347] [1348] [1349] . Cancer Research Campaign 1998 with a raised preoperati-e CEA had a -orse 5-year survival (39c) than those w-ith a normal preoperatixe CEA (57%7r) (Ftaure 2: hazard ratio 2.04: 95%7-confidence intervals 1.4-2.9: log rank test P = 0.0001). How-ever. when tumour staae was controlled for. the survival benefit of a low-preoperative CEA was lost (hazard ratio 1.28: 95%/c confidence intervals 0.87-1.88: log rank test P = 0.20). (Moertel et al. 1986 ). Wanebo et al (1978) studied 358 patients with colorectal cancer and found that the recurrence rate was higher in patients with Dukes' B and C lesions if their preoperative CEA was greater than 5 ng ml-'. this was hiahl1v statistically significant within the two stages. Thev also found a linear correlation bet-een preoperatiVe CEA levels and estimated mean recurrence time. In contrast to this. Goslin et al. (1980) found no correlation between preoperative CEA levels and risk of tumour recurrence in 71 stage B tumours. but there was a highly significant correlation between CEA levels and recurrence in 46 patients with stage C tumours.
DISCUSSION
Interestingly. if the poorly differentiated stage C tumours are removed. this difference in recurrence rates becomes even more sianificant. They suggested that poorly differentiated tumours produce little tissue CEA. and this is reflected in low serum CEA levels. However. this study has been unable to confirm this observation: rather an elevated CEA was associated with poorly differentiated tumours. Lewi et al ( 1984) obtained similar results to Goslin et al ( 1980) : 102 patients with stage C tumours and a preoperati-e CEA level grreater than 100 prg 1-' (equivalent to 40 igo ml-' in Goslin's study) showed a sianificantly decreased 2-and 5-vear survival compared with those with a lower CEA. They found no correlation between preoperative CEA and disease-free survival for stage B tumours.
Moertel et al (1986) measured preoperative CEA in 316 patients undergoing surgery for colorectal cancer and obtained complete 5-year follow-up. Preoperative CEA levels were significantly correlated with stage of disease and with the size of the primarv tumour in stagye B tumours. There was no association between preoperative CEA and survival for stage A. B or C tumours with 1-3 nodes involved. However. it was an independent predictor of survival in patients whose tumours had four or more metastaticallv involved lymph nodes. This finding. which is similar to our results. has also been confirmed by Filella et al (1992) . Others usin, a panel of serum markers including CEA measured preoperatively have also been unable to show any benefit over Dukes' staginc in predictingy survival (Diez et al. 1994 : Lindmark et al. 1995 .
In contrast. the Japanese report a different experience regarding the ability of preoperative CEA level to predict survival. independent of tumour stace. Multivariate analysis on data pooled from 1254 patients w-ith colorectal cancer revealed that an elevated preoperative CEA as well as nodal involvement and -enous invasion were independent factors affecting disease-free survival (Takahashi et al. 1996) . Tsuchiva et al (1994) . (McCall et al. 1994 : Vauthev et al. 1996 .
This study concludes that a raised preoperative serum CEA is associated with a poorer proanosis and more advanced tumour stage but is of little value in predicting, patient survival once the Dukes' staae is known.
